Atrial stunning: Basics and clinical considerations

International Journal of Cardiology

Volumn 92, Issue 2-3, 2003, Pages 113-128

  Khan, Ijaz A ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial arrhythmias; Atrial fibrillation; Atrial flutter; Atrial function; Atrial mechanical dysfunction; Atrial stunning; Cardioversion; Differential atrial stunning; Thromboembolism

Indexed keywords

ACETYLSTROPHENATHIDINE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DILTIAZEM; DOFETILIDE; FLECAINIDE; INOTROPIC AGENT; ISOPRENALINE; PROPAFENONE; SOTALOL; UNCLASSIFIED DRUG; VERAPAMIL;

BLOOD; CALCIUM TRANSPORT; CARDIOVERSION; CLINICAL TRIAL; CYTOSOL; DENSITY; DOSE RESPONSE; DRUG EFFECT; ELECTRIC SHOCK; ELECTROSTIMULATION; FLOW RATE; HEART ARRHYTHMIA; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART PROTECTION; HEART SIZE; HEART VENTRICLE OVERLOAD; HUMAN; LEFT ATRIUM STUNNING; LUNG EDEMA; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; RIGHT ATRIUM STUNNING; SINUS RHYTHM; STUNNED HEART MUSCLE; TACHYCARDIA INDUCED CARDIOMYOPATHY; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0345097413     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(03)00107-4     Document Type: Review

References (125)

1. Logan W.F., Rowlands D.J., Howitt G., Holmes A.M. Left atrial activity following cardioversion. Lancet. 2:1965;471-473.
2. Ikram H., Nixon P.G., Arcan T. Left atrial function after electrical conversion to sinus rhythm. Br Heart J. 30:1968;80-83.
3. Khan I.A. Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter. Am Heart J. 144:2002;11-22.
4. Shapiro E.P., Effron M.B., Lima S., Ouyang P., Siu C.O., Bush D. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol. 62:1988;1202-1207.
5. Manning W.J., Leeman D.E., Gotch P.J., Come P.C. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol. 13:1989;617-623.
6. Grimm R.A., Stewart W.J., Maloney J.D., et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 22:1993;1359-1366.
7. Jordaens L., Missault L., Germonpre E., et al. Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion. Am J Cardiol. 71:1993;63-67.
8. Fatkin D., Kuchar D.L., Thorburn C.W., Feneley M.P. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for atrial stunning as a mechanism of thromboembolic complications. J Am Coll Cardiol. 23:1994;307-316.
9. Manning W.J., Silverman D.I., Katz S.E., et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 23:1994;1535-1540.
10. Manning W.J., Silverman D.I., Katz S.E., et al. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol. 75:1995;624-626.
11. Grimm R.A., Leung D.Y., Black I.W., Stewart W.J., Thomas J.D., Klein A.L. Left atrial appendage stunning after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. Am Heart J. 130:1995;174-176.
12. Falcone R.A., Morady F., Armstrong W.F. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. Am J Cardiol. 78:1996;435-439.
13. Mattioli A.V., Tarabini Castellani E., Vivoli D., Molinari R., Mattioli G. Restoration of atrial function after atrial fibrillation of different etiological origins. Cardiology. 87:1996;205-211.
14. Tabata T., Oki T., Iuchi A., et al. Evaluation of left atrial appendage function by measurement of changes in flow velocity patterns after electrical cardioversion in patients with isolated atrial fibrillation. Am J Cardiol. 79:1997;615-620.
15. Omran H., Jung W., Rabahieh R., et al. Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol. 29:1997;131-138.
16. Harjai K.J., Mobarek S.K., Cheirif J., Boulos L.M., Murgo J.P., Abi-Samra F. Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation. J Am Coll Cardiol. 30:1997;481-486.
17. Irani W.N., Grayburn P.A., Afridi I. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. Circulation. 95:1997;962-966.
18. Grimm R.A., Stewart W.J., Arheart K., Thomas J.D., Klein A.L. Left atrial appendage stunning after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol. 29:1997;582-589.
19. Louie E.K., Liu D., Reynertson S.I., et al. Stunning of the left atrium after spontaneous conversion of atrial fibrillation to sinus rhythm: demonstration by transesophageal Doppler techniques in a canine model. J Am Coll Cardiol. 32:1998;2081-2086.
20. Harjai K., Mobarek S., Abi-Samra F., et al. Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion. Am J Cardiol. 81:1998;1125-1129.
21. Bellotti P., Spirito P., Lupi G., Vecchio C. Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation. Am J Cardiol. 81:1998;1199-1202.
22. Sparks P.B., Jayaprakash S., Vohra J.K., et al. Left atrial stunning following radiofrequency catheter ablation of chronic atrial flutter. J Am Coll Cardiol. 32:1998;468-475.
23. Weiss R., Marcovitz P., Knight B.P., et al. Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter. Am J Cardiol. 82:1998;1052-1055.
24. Kontos M.C., Paulsen W.H. Impairment of left atrial appendage function after spontaneous conversion of atrial flutter. Clin Cardiol. 21:1998;769-771.
25. Ciolli A., De Sisti A., Montenero A.S., Sanna T., Lo Sardo G., Palamara A. Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion. Cardiologia. 43:1998;1077-1082.
26. Paventi S., Parafati M.A., Pellegrino C.A., Bevilacqua U., Paggi A. Atrial stunning and pharmacologic cardioversion in idiopathic atrial fibrillation of recent onset. Minerva Cardioangiol. 47:1999;239-244.
27. Mattioli A.V., Castelli A., Bastia E., Mattioli G. Atrial ejection force in patients with atrial fibrillation: comparison between DC shock and pharmacological cardioversion. Pacing Clin Electrophysiol. 22:1999;33-38.
28. Antonielli E., Pizzuti A., Bassignana A., et al. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. Am J Cardiol. 84:1999;1092-1096.
29. Sparks P.B., Jayaprakash S., Mond H.G., Vohra J.K., Grigg L.E., Kalman J.M. Left atrial mechanical function after brief duration atrial fibrillation. J Am Coll Cardiol. 33:1999;342-349.
30. Daoud E.G., Marcovitz P., Knight B.P., et al. Short-term effect of atrial fibrillation on atrial contractile function in humans. Circulation. 99:1999;3024-3027.
31. Mattioli A.V., Sansoni S., Lucchi G.R., Mattioli G. Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function. Am J Cardiol. 85:2000;832-836.
32. Missault L., Jordaens L., Gheeraert P., Adang L., Clement D. Embolic stroke after unanticoagulated cardioversion despite prior exclusion of atrial thrombi by transoesophageal echocardiography. Eur Heart J. 15:1994;1279-1280.
33. Van Gelder I.C., Crijns H.J., Blanksma P.K., et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 72:1993;560-566.
34. Lipkin D.P., Frenneaux M., Stewart R., Joshi J., Lowe T., McKenna W.J. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J. 59:1988;572-577.
35. Levy S. Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol. 9:1998;S78-82.
36. Chugh S.S., Blackshear J.L., Shen W., Hammill S.C., Gersh B.J. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 37:2001;371-378.
37. Arnold A.Z., Mick M.J., Mazurek R.P., Loop F.D., Trohman R.G. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 19:1992;851-855.
38. Weinberg D.M., Mancini J. Anticoagulation for cardioversion of atrial fibrillation. Am J Cardiol. 63:1989;745-746.
39. Gardner M.J., Gilbert M. Heart rate control in patients with atrial fibrillation. Can J Cardiol. 12:1996;21A-23A.
40. Shettigar U.R., Toole J.G., Appunn D.O. Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation and flutter. Am Heart J. 126:1993;369-374.
41. Wattanasuwan N., Khan I.A., Mehta N.J., et al. Acute ventricular rate control in atrial fibrillation. IV. Combination of diltiazem and digoxin vs. i.v. diltiazem alone. Chest. 119:2001;502-506.
42. Tavel M.E., Sopher S.M., Camm A.J. Atrial fibrillation: problems in management. Chest. 110:1996;1089-1091.
43. Khan I.A. Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol. 87:2003;121-128.
44. Levy S. Restoring sinus rhythm in atrial fibrillation: electrical or pharmacological cardioversion. Ann Noninvas Electrocardiol. 3:1998;109-114.
45. Khan I.A. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. J Am Coll Cardiol. 37:2001;542-547.
46. Golzari H., Cebul R.D., Bahler R.C. Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med. 125:1996;311-323.
47. Roy D., Marchand E., Gagne P., Chabot M., Cartier R. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J. 112:1986;1039-1043.
48. Black I.W., Fatkin D., Sagar K.B., et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation. 89:1994;2509-2513.
49. Veinot J.P., Harrity P.J., Gentile F., et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation. 96:1997;3112-3115.
50. Pollick C., Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography: implications for the development of thrombus. Circulation. 84:1991;223-231.
51. Seward J.B., Khandheria B.K., Freeman W.K., et al. Multiplane transesophageal echocardiography: image orientation, examination technique, anatomic correlations, and clinical applications. Mayo Clin Proc. 68:1993;523-551.
52. DeMaria A.N., Lies J.E., King J.F., Miller R.R., Amsterdam E.A., Mason D.T. Echographic assessment of atrial transport, mitral movement, and ventricular performance following electroversion of supraventricular arrhythmias. Circulation. 51:1975;273-282.
53. Chan S.K., Kannam J.P., Douglas P.S., Manning W.J. Multiplane transesophageal echocardiographic assessment of left atrial appendage anatomy and function. Am J Cardiol. 76:1995;528-530.
54. Sigel B., Coelho J.C., Spigos D.G., et al. Ultrasonography of blood during stasis and coagulation. Invest Radiol. 16:1981;71-76.
55. Merino A., Hauptman P., Badimon L., et al. Echocardiographic smoke is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol. 20:1992;1661-1668.
56. de Kroon M.G., Slager C.J., Gussenhoven W.J., Serruys P.W., Roelandt J.R., Bom N. Cyclic changes of blood echogenicity in high-frequency ultrasound. Ultrasound Med Biol. 17:1991;723-728.
57. Daniel W.G., Nellessen U., Schroder E., et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol. 11:1988;1204-1211.
58. Beppu S., Nimura Y., Sakakibara H., Nagata S., Park Y.D., Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. J Am Coll Cardiol. 6:1985;744-749.
59. Chia B.L., Choo M.H., Yan P.C., Ee B.K., Lee C.N., Shears J.H. Intra-atrial smoke-like echoes and thrombi formation. Chest. 95:1989;912-914.
60. Castello R., Pearson A.C., Labovitz A.J. Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography. Am J Cardiol. 65:1990;1149-1153.
61. Tsai L.M., Chen J.H., Fang C.J., Lin L.J., Kwan C.M. Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol. 70:1992;327-331.
62. de Belder M.A., Lovat L.B., Tourikis L., Leech G., Camm A. Left atrial spontaneous contrast echoes: markers of thromboembolic risk in patients with atrial fibrillation. Eur Heart J. 14:1993;326-335.
63. Black I.W., Hopkins A.P., Lee L.C., Walsh W.F. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 18:1991;398-404.
64. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med. 128:1998;639-647.
65. Fatkin D., Kelly R.P., Feneley M.P. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 23:1994;961-969.
66. Mikael Kortz R.A., Delemarre B.J., van Dantzig J.M., Bot H., Kamp O., Visser C.A. Left atrial appendage blood flow determined by transesophageal echocardiography in healthy subjects. Am J Cardiol. 71:1993;976-981.
67. Tabata T., Oki T., Fukuda N., et al. Influence of aging on left atrial appendage flow velocity patterns in normal subjects. J Am Soc Echocardiogr. 9:1996;274-280.
68. Mugge A., Kuhn H., Nikutta P., Grote J., Lopez J.A., Daniel W.G. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol. 23:1994;599-607.
69. Noda T., Arakawa M., Miwa H., et al. Effects of heart rate on flow velocity of the left atrial appendage in patients with nonvalvular atrial fibrillation. Clin Cardiol. 19:1996;295-300.
70. Li Y.H., Lai L.P., Shyu K.G., et al. Clinical implications of left atrial appendage function: its influence on thrombus formation. Int J Cardiol. 43:1994;61-66.
71. Jue J., Winslow T., Fazio G., Redberg R.F., Foster E., Schiller N.B. Pulsed Doppler characterization of left atrial appendage flow. J Am Soc Echocardiogr. 6:1993;237-244.
72. Pozzoli M., Febo O., Torbicki A., et al. Left atrial appendage dysfunction: a cause of thrombosis. Evidence by transesophageal echocardiography-Doppler studies. J Am Soc Echocardiogr. 4:1991;435-441.
73. Hondo T., Okamoto M., Yamane T., et al. The role of the left atrial appendage. A volume loading study in open-chest dogs. Jpn Heart J. 36:1995;225-234.
74. Kamp O., Verhorst P.M., Welling R.C., Visser C.A. Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J. 20:1999;979-985.
75. Panagiotopoulos K., Toumanidis S., Saridakis N., Vemmos K., Moulopoulos S. Left atrial and left atrial appendage functional abnormalities in patients with cardioembolic stroke in sinus rhythm and idiopathic atrial fibrillation. J Am Soc Echocardiogr. 11:1998;711-719.
76. Li Y.H., Lai L.P., Shyu K.G., Hwang J.J., Kuan P., Lien W.P. Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. Chest. 105:1994;748-752.
77. Rubin D.N., Katz S.E., Riley M.F., Douglas P.S., Manning W.J. Evaluation of left atrial appendage anatomy and function in recent-onset atrial fibrillation by transesophageal echocardiography. Am J Cardiol. 78:1996;774-778.
78. Sparks P.B., Kulkarni R., Vohra J.K., et al. Effect of direct current shocks on left atrial mechanical function in patients with structural heart disease. J Am Coll Cardiol. 31:1998;1395-1399.
79. Dodds G.A., Wilkinson W.E., Greenfield R.A., Natale A., Kisslo J., Pritchett E.L. Evaluation of the effect of transthoracic cardioversion from ventricular tachycardia to sinus rhythm on left atrial mechanical function. Am J Cardiol. 78:1996;1436-1439.
80. Agmon Y., Khandheria B.K., Gentile F., Seward J.B. Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol. 34:1999;1867-1877.
81. Santiago D., Warshofsky M., Li Mandri G., et al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol. 24:1994;159-164.
82. Omran H., Jung W., Rabahieh R., et al. Left atrial appendage function in patients with atrial flutter. Heart. 78:1997;250-254.
83. Stoddard M.F., Dawkins P.R., Prince C.R., Longaker R.A. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J. 129:1995;1204-1215.
84. Trouton T.G., Allen J.D., Yong L.K., Rooney J.J., Adgey A.A. Metabolic changes and mitochondrial dysfunction early following transthoracic countershock in dogs. Pacing Clin Electrophysiol. 12:1989;1827-1834.
85. Fatkin D., Loupas T., Feneley M.P. Direct effects of DC cardioversion on blood echogenicity: an in vitro study. Ultrasound Med Biol. 23:1997;135-142.
86. Khan I.A. Atrial stunning: determinants and cellular mechanisms. Am Heart J. 145:2003;787-794.
87. Sanders P., Morton J.B., Morgan J.G., et al. Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation. 106:2002;1806-1813.
88. Daoud E.G., Bogun F., Goyal R., et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 94:1996;1600-1606.
89. Yu W.C., Chen S.A., Lee S.H., et al. Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs. Circulation. 97:1998;2331-2337.
90. Sun H., Gaspo R., Leblanc N., Nattel S. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation. 98:1998;719-727.
91. Lee H.C., Clusin W.T. Cytosolic calcium staircase in cultured myocardial cells. Circ Res. 61:1987;934-939.
92. Thandroyen F.T., Morris A.C., Hagler H.K., et al. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ Res. 69:1991;810-819.
93. Kitakaze M., Weisman H.F., Marban E. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation. 77:1988;685-695.
94. Leistad E., Aksnes G., Verburg E., Christensen G. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation. 93:1996;1747-1754.
95. Ausma J., Wijffels M., van Eys G., et al. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation. Am J Pathol. 151:1997;985-997.
96. Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 96:1997;3157-3163.
97. Wouters L., Liu G.-S., Flameng W., Thijssen V., Thone F., Borgers M. Structural remodeling of atrial myocardium in patients with cardiac valve disease and atrial fibrillation. Exp Clin Cardiol. 5:2000;158-163.
98. Sadoshima J., Takahashi T., Jahn L., Izumo S. Roles of mechano-sensitive ion channels, cytoskeleton, and contractile activity in stretch-induced immediate-early gene expression and hypertrophy of cardiac myocytes. Proc Natl Acad Sci. 89:1992;9905-9909.
99. Yamazaki T., Komuro I., Yazaki Y. Molecular mechanism of cardiac cellular hypertrophy by mechanical stress. J Mol Cell Cardiol. 27:1995;133-140.
100. Thompson E.W., Marino T.A., Uboh C.E., Kent R.L., Cooper G. Atrophy reversal and cardiocyte redifferentiation in reloaded cat myocardium. Circ Res. 54:1984;367-377.
101. Sharp W.W., Terracio L., Borg T.K., Samarel A.M. Contractile activity modulates actin synthesis and turnover in cultured neonatal rat heart cells. Circ Res. 73:1993;172-183.
102. Mary-Rabine L., Albert A., Pham T.D., et al. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ Res. 52:1983;188-199.
103. Altemose G.T., Zipes D.P., Weksler J., Miller J.M., Olgin J.E. Inhibition of the Na(+)/H(+) exchanger delays the development of rapid pacing-induced atrial contractile dysfunction. Circulation. 103:2001;762-768.
104. Pollak A., Falk R.H. Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol. 25:1995;665-671.
105. Dan G.A., Gonta A. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation. Rom J Intern Med. 35:1997;19-27.
106. DeCara J.M., Pollak A., Dubrey S., Falk R.H. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. Am J Cardiol. 86:2000;685-688.
107. Friedman H.S., Win M., Hussain A., Sinha A. Effects of cardiac glycosides on atrial contractile dysfunction after short-term atrial fibrillation. Chest. 118:2000;1116-1126.
108. Date T., Takahashi A., Iesaka Y., et al. Effect of low-dose isoproterenol infusion on left atrial appendage function soon after cardioversion of chronic atrial tachyarrhythmias. Int J Cardiol. 84:2002;59-67.
109. Twidale N., Roberts-Thomson P., McRitchie R.J. Comparative hemodynamic effects of amiodarone, sotalol, and D-sotalol. Am Heart J. 126:1993;122-129.
110. Tieleman R.G., De Langen C., Van Gelder I.C., et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation. 95:1997;1945-1953.
111. Fozzard H.A., Sheets M.F. Cellular mechanism of action of cardiac glycosides. J Am Coll Cardiol. 5:1985;10A-15A.
112. Katz A.M. Effects of digitalis on cell biochemistry: sodium pump inhibition. J Am Coll Cardiol. 5:1985;16A-21A.
113. Becker L.C., Levine J.H., DiPaula A.F., Guarnieri T., Aversano T. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol. 7:1986;580-589.
114. Friedman H.S., Rodney E., Sinha B., et al. Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect. J Invest Med. 47:1999;293-303.
115. de Divitiis M., Omran H., Rabahieh R., et al. Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors. Am J Cardiol. 84:1999;1023-1028.
116. Oram S., Davies J.P. Further experience of electrical cardioversion of atrial fibrillation to sinus rhythm: analysis of 100 patients. Lancet. 1:1964;1294-1298.
117. Siddiqui M.A., Khan I.A. Transgastric and transesophageal echocardiographic views of right atrial appendage. J Clin Basic Cardiol. 4:2001;301.
118. Omran H., Jung W., MacCarter D., et al. Right atrial thrombi and depressed right atrial appendage function after cardioversion of atrial fibrillation. Echocardiography. 16:1999;245-251.
119. Lehmann G., Horcher J., Dennig K., Plewan A., Ulm K., Alt E. Atrial mechanical performance after internal and external cardioversion of atrial fibrillation: an echocardiographic study. Chest. 121:2002;13-18.
120. Upshaw C.B. Jr. Hemodynamic changes after cardioversion of chronic atrial fibrillation. Arch Intern Med. 157:1997;1070-1076.
121. Gowda R.M., Misra D., Khan I.A., Schweitzer P. Acute pulmonary edema after successful electrical cardioversion of atrial fibrillation. Am J Ther. 10:2003;73-74.
122. Mazzone C., Pandullo C., Scardi S., et al. Left atrial and appendage mechanical function after pharmacological or electrical cardioversion in patients with chronic atrial fibrillation: a multicenter, randomized study. Ital Heart J. 1:2000;128-136.
123. Berger M., Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol. 82:1998;1545-1547.
124. Dunn M.I., Marcum J.L. Atrial mechanical performance following internal and external cardioversion of atrial fibrillation: its relationship to peripheral embolization and acute cerebrovascular accident. Chest. 121:2002;1-3.
125. de Luca I., Sorino M., Del Salvatore B., de Luca L. A new therapeutic strategy for electrical cardioversion of atrial fibrillation. Ital Heart J. 2:2001;831-840.